No serious health effects linked to mRNA COVID-19 vaccines
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California
About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.
Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy
Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.
It’s flu season: What you need to know about the research
What does it take to be sure the annual flu vaccine is effective and safe? Research. In a podcast, Nicola Klein, head of the Vaccine Study Center, tackles some common questions about the vaccine and recent findings.
Study identifies geographic clusters of pregnant women who missed flu shots
A Kaiser Permanente analysis of women who did not get flu shots during their pregnancies found the women clustered in geographic “hot spots.” These women tended to have fewer prenatal medical visits and live in low-income neighborhoods.
Kaiser Permanente joins late-stage COVID-19 vaccine study
The Division of Research has joined a phase 3 clinical trial testing a Pfizer/BioNTech vaccine against the COVID-19 virus. Kaiser Permanente Southern California and Northwest join them in this global effort.
Study finds no evidence of harm to infant development after mothers get flu vaccine while pregnant
A Kaiser Permanente study of women who were given inactivated influenza vaccine while pregnant found no indication of developmental problems for their babies at 6 months old.
Waning potency of pertussis vaccine a significant contributor to recent whooping cough outbreaks
Children who were up to date on their pertussis vaccine schedule were far less likely to develop the disease than those unvaccinated. The risk of vaccinated children becoming ill increased with time since vaccination, suggesting waning effectiveness.
The New Faces of Health Care Research, Pt. 2
In part 2 of our profile series, meet the last three of the seven early-career researchers who began their post-doctoral appointments this past year and represent not only diverse communities but diverse research interests as well.
Work by the Division of Research Makes Top JAMA Lists for 2018
The JAMA Network, the publication home for numerous top-tier journals from the American Medical Association, released a list of the “Most Talked About Articles” in each of their various publications for 2018. DOR research appears on four lists.
